Clinical Trials Directory

Trials / Unknown

UnknownNCT03079271

An Open Label Comparing the Short Term Efficacy of Lacrisert

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Virginia Eye Consultants · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To evaluate the short term effects of LACRISERT®. upon fluorescein corneal staining, tear osmolarity and surface topography in human subjects with dry eye disease.

Conditions

Interventions

TypeNameDescription
DRUGLacrisert, 5 Mg Ophthalmic Insert

Timeline

Start date
2016-11-01
Primary completion
2017-06-01
Completion
2017-12-01
First posted
2017-03-14
Last updated
2017-03-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03079271. Inclusion in this directory is not an endorsement.